Companies / Brazil
Novartis Brazil Unit Plans Easier US Exports
May 2006 | Company Finance AlertSwiss drug major Novartis is negotiating with Brazilian officials in order to streamline the registration of drugs to be exported from Brazil. Currently, exports account for just 10% of the Brazilian subsidiary's revenues, which totalled BRL1.8bn (US$793mn) in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
